Search

Search Constraints

You searched for: Author/Creator Cheeseman, M.

Search Results

3. Discovery and validation of biomarkers to support clinical development of NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitor. (October 2022)

4. Investigating the effects of ERAP1 inhibition on antigen presentation and the tumour immune response. (October 2022)